Back to Journals » Cancer Management and Research » Volume 13

Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review

Total article views   HTML views PDF downloads Totals
4,920 Dovepress* 4,432+ 417 4,849
PubMed Central* 488 170 658
Totals 4,920 587 5,507
*Since 9 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar